These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38899900)

  • 1. Optimization of immunosuppression strategies for the establishment of chronic hepatitis E virus infection in rabbits.
    He Q; Liu T; Yang X; Yuan D; Lu Q; Li Y; Zhang H; Liu X; Xia C; Sridhar S; Tian L; Liu X; Meng L; Ning J; Lu F; Wang L; Yin X; Wang L
    J Virol; 2024 Jul; 98(7):e0084624. PubMed ID: 38899900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
    Gardinali NR; Guimarães JR; Melgaço JG; Kevorkian YB; Bottino FO; Vieira YR; da Silva AC; Pinto DP; da Fonseca LB; Vilhena LS; Uiechi E; da Silva MC; Moran J; Marchevsky RS; Cruz OG; Otonel RA; Alfieri AA; de Oliveira JM; Gaspar AM; Pinto MA
    PLoS One; 2017; 12(3):e0174070. PubMed ID: 28328941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
    Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
    Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocompromised rabbit model of chronic HEV reveals liver fibrosis and distinct efficacy of different vaccination strategies.
    He Q; Zhang F; Shu J; Li S; Liang Z; Du M; Liu X; Liu T; Li M; Yin X; Pan Q; Lu F; Wang L; Wang L
    Hepatology; 2022 Sep; 76(3):788-802. PubMed ID: 35278241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects and efficacy of renal sparing immunosuppression in pediatric liver transplantation-A single center matched cohort study.
    Leiskau C; Rajanayagam J; Pfister ED; Goldschmidt I; Junge N; Karch A; Lerch C; Richter N; Lehner F; Schrem H; Baumann U
    Pediatr Transplant; 2018 Aug; 22(5):e13207. PubMed ID: 29729061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MMF Immunosuppression Based on CNI Reduction on CNI-Related Renal Damage after Lung Transplantation.
    Tang C; Wang W; Xue Y; Yang J
    J Healthc Eng; 2022; 2022():8099684. PubMed ID: 35126949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
    Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
    Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.
    Shao ZY; Yan LN; Wang WT; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG
    World J Gastroenterol; 2012 Mar; 18(9):991-8. PubMed ID: 22408361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
    Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
    Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and determinants of chronicity in hepatitis E virus infection.
    Narayanan S; Abutaleb A; Sherman KE; Kottilil S
    J Viral Hepat; 2019 Apr; 26(4):414-421. PubMed ID: 30636092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
    Chen S; Wei F; Wu T; Xia N
    Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.
    Ekberg H; Grinyó J; Nashan B; Vanrenterghem Y; Vincenti F; Voulgari A; Truman M; Nasmyth-Miller C; Rashford M
    Am J Transplant; 2007 Mar; 7(3):560-70. PubMed ID: 17229079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small animal model of chronic hepatitis E infection using immunocompromised rats.
    Sridhar S; Wu S; Situ J; Shun EH; Li Z; Zhang AJ; Hui K; Fong CH; Poon VK; Chew NF; Yip CC; Chan WM; Cai JP; Yuen KY
    JHEP Rep; 2022 Oct; 4(10):100546. PubMed ID: 36052220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to improve the survival of the kidney transplant - is it only the pharmaceutical management?
    Spasovski G; Masin-Spasovska J
    Expert Opin Pharmacother; 2014 May; 15(7):905-8. PubMed ID: 24617949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.